Hypertension, Vol 9, 139-143, Copyright © 1987 by American Heart Association
A Overlack, JG Zenzen, C Ressel, HM Muller and KO Stumpe
The influence of long-term alterations in dietary magnesium intake on blood
pressure and on the antihypertensive effect of the calcium antagonist
nifedipine was investigated in normotensive Wistar-Kyoto (WKY) and in
spontaneously hypertensive rats (SHR). The rats were fed a diet either high
(1%), normal (0.1%), or low (0.01%) in magnesium for 12 weeks (WKY) and 20
weeks (SHR), respectively. Nifedipine was added to the diet for 4 weeks in
concentrations of 300 and 1000 ppm. Each dose was given for 2 weeks. Plasma
and intraerythrocytic concentrations of sodium, potassium, and magnesium
were measured before and at the end of nifedipine treatment. Blood was
obtained by cardiac puncture. In the WKY and SHR, blood pressure was not
influenced by magnesium intake. The blood pressure-lowering effect of
nifedipine was most pronounced on normal dietary magnesium and was
significantly suppressed in the magnesium-deficient rats. Plasma and
intracellular total magnesium concentrations were consistently increased
during high and reduced during low dietary intake of the ion. Intracellular
sodium concentration increased during magnesium deficiency and was
normalized by nifedipine. The marked and long-term alterations in plasma
and intracellular concentrations of magnesium did not influence arterial
blood pressure levels in either the normotensive WKY or the SHR. Therefore,
dietary magnesium intake does not appear to play an important role in
long-term regulation of blood pressure in rats. However, magnesium
depletion attenuates the blood pressure-lowering effect of nifedipine.
ARTICLES
Influence of magnesium on blood pressure and the effect of nifedipine in rats
This article has been cited by other articles:
![]() |
H. Iso, M. J. Stampfer, J. E. Manson, K. Rexrode, C. H. Hennekens, G. A. Colditz, F. E. Speizer, and W. C. Willett Prospective Study of Calcium, Potassium, and Magnesium Intake and Risk of Stroke in Women Stroke, September 1, 1999; 30(9): 1772 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Cummings, P. Amadio Jr, L. Nelson, and J. M. Fitzgerald The Role of Calcium Channel Blockers in the Treatment of Essential Hypertension Arch Intern Med, February 1, 1991; 151(2): 250 - 259. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |